USD 16.18
(-4.94%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 375.5 Million USD | -12.15% |
2022 | 376 Million USD | 5.8% |
2021 | 355.4 Million USD | -15.26% |
2020 | 419.4 Million USD | -8.41% |
2019 | 457.9 Million USD | 17.29% |
2018 | 390.4 Million USD | 2.74% |
2017 | 380 Million USD | -19.23% |
2016 | 470.5 Million USD | 8.09% |
2015 | 435.3 Million USD | -4.18% |
2014 | 454.3 Million USD | 17.42% |
2013 | 386.9 Million USD | 3.31% |
2012 | 374.5 Million USD | -1.47% |
2011 | 380.1 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 79.5 Million USD | -9.04% |
2024 Q3 | 80.9 Million USD | -4.15% |
2024 Q1 | 87.4 Million USD | 16.22% |
2023 Q3 | 94.3 Million USD | -5.61% |
2023 Q2 | 99.9 Million USD | -1.96% |
2023 Q1 | 101.9 Million USD | 12.35% |
2023 FY | 330.3 Million USD | -12.15% |
2023 Q4 | 75.2 Million USD | -20.25% |
2022 FY | 376 Million USD | 5.8% |
2022 Q4 | 90.7 Million USD | -0.77% |
2022 Q3 | 91.4 Million USD | -4.69% |
2022 Q2 | 95.9 Million USD | -2.14% |
2022 Q1 | 98 Million USD | 36.3% |
2021 Q2 | 93 Million USD | -10.32% |
2021 Q4 | 71.9 Million USD | -17.17% |
2021 FY | 355.4 Million USD | -15.26% |
2021 Q3 | 86.8 Million USD | -6.67% |
2021 Q1 | 103.7 Million USD | -22.44% |
2020 Q2 | 88.3 Million USD | -13.0% |
2020 Q1 | 101.5 Million USD | -10.1% |
2020 Q3 | 95.9 Million USD | 8.61% |
2020 FY | 419.4 Million USD | -8.41% |
2020 Q4 | 133.7 Million USD | 39.42% |
2019 Q4 | 112.9 Million USD | -0.18% |
2019 Q2 | 108.5 Million USD | -12.07% |
2019 Q3 | 113.1 Million USD | 4.24% |
2019 Q1 | 123.4 Million USD | 13.52% |
2019 FY | 457.9 Million USD | 17.29% |
2018 FY | 390.4 Million USD | 2.74% |
2018 Q4 | 108.7 Million USD | 11.26% |
2018 Q3 | 97.7 Million USD | 13.74% |
2018 Q2 | 85.9 Million USD | -12.44% |
2018 Q1 | 98.1 Million USD | 192.84% |
2017 Q3 | 114.5 Million USD | -0.78% |
2017 FY | 380 Million USD | -19.23% |
2017 Q4 | 33.5 Million USD | -70.74% |
2017 Q2 | 115.4 Million USD | -1.03% |
2017 Q1 | 116.6 Million USD | -8.12% |
2016 Q3 | 117.1 Million USD | -4.87% |
2016 FY | 470.5 Million USD | 8.09% |
2016 Q4 | 126.9 Million USD | 8.37% |
2016 Q2 | 123.1 Million USD | 19.05% |
2016 Q1 | 103.4 Million USD | -9.77% |
2015 FY | 435.3 Million USD | -4.18% |
2015 Q4 | 114.6 Million USD | -1.8% |
2015 Q3 | 116.7 Million USD | 3.46% |
2015 Q2 | 112.8 Million USD | 23.68% |
2015 Q1 | 91.2 Million USD | -31.17% |
2014 Q1 | 93.3 Million USD | -4.5% |
2014 FY | 454.3 Million USD | 17.42% |
2014 Q2 | 109.4 Million USD | 17.26% |
2014 Q4 | 132.5 Million USD | 11.25% |
2014 Q3 | 119.1 Million USD | 8.87% |
2013 Q2 | 97.1 Million USD | -3.77% |
2013 Q4 | 97.7 Million USD | 7.13% |
2013 Q1 | 100.9 Million USD | 0.0% |
2013 FY | 386.9 Million USD | 3.31% |
2013 Q3 | 91.2 Million USD | -6.08% |
2012 FY | 374.5 Million USD | -1.47% |
2011 FY | 380.1 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Abbott Laboratories | 15.71 Billion USD | 97.61% |
Allurion Technologies Inc. | 120.57 Million USD | -211.424% |
Artivion, Inc. | 223.43 Million USD | -68.059% |
Butterfly Network, Inc. | 162.46 Million USD | -131.125% |
Butterfly Network, Inc. | 162.46 Million USD | -131.125% |
Bio-Rad Laboratories, Inc. | 1.04 Billion USD | 64.154% |
Boston Scientific Corporation | 7.47 Billion USD | 94.979% |
Perspective Therapeutics, Inc. | 17.42 Million USD | -2054.826% |
CONMED Corporation | 564.24 Million USD | 33.451% |
Edwards Lifesciences Corporation | 3.09 Billion USD | 87.851% |
Paragon 28, Inc. | 210.1 Million USD | -78.724% |
Glaukos Corporation | 367.83 Million USD | -2.084% |
Globus Medical, Inc. | 887.16 Million USD | 57.674% |
Inspire Medical Systems, Inc. | 568.49 Million USD | 33.948% |
Integer Holdings Corporation | 250.95 Million USD | -49.626% |
Medtronic plc | 16.12 Billion USD | 97.672% |
Nevro Corp. | 389.36 Million USD | 3.562% |
Owlet, Inc. | 51.21 Million USD | -633.126% |
Penumbra, Inc. | 590.87 Million USD | 36.45% |
Vicarious Surgical Inc. | 80.66 Million USD | -365.5% |
Smith & Nephew plc | 3.46 Billion USD | 89.169% |
Sonendo, Inc. | 68.46 Million USD | -448.455% |
STERIS plc | 1.4 Billion USD | 73.186% |
Stryker Corporation | 9.2 Billion USD | 95.922% |
Vapotherm, Inc. | 66.02 Million USD | -468.724% |
Zimmer Biomet Holdings, Inc. | 3.27 Billion USD | 88.538% |